Cargando…

Gliflozine – in Zukunft Kardioprotektiva?

Gliflozine (inhibitors of sodium-dependent glucose cotransporters, SGLT) are medications which were originally used in the treatment of diabetes mellitus and are assigned to the group of antidiabetics. Since November 2020 the SGLT2 inhibitor dapagliflozin has been approved for the treatment of heart...

Descripción completa

Detalles Bibliográficos
Autores principales: Rauch-Kröhnert, Ursula, Landmesser, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260408/
https://www.ncbi.nlm.nih.gov/pubmed/34164700
http://dx.doi.org/10.1007/s00108-021-01083-0